These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13688354)

  • 1. Titers of complement fixing measles antibodies in human sera collected from one to five years after illness.
    BECH V
    Acta Pathol Microbiol Scand; 1960; 50():81-8. PubMed ID: 13688354
    [No Abstract]   [Full Text] [Related]  

  • 2. Titers of complement fixing measles antibodies in sera collected at random from healthy persons in Copenhagen.
    BECH V
    Acta Pathol Microbiol Scand; 1960; 50():322-30. PubMed ID: 13688355
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the content of complement fixing measles antibodies in serum fractions obtained by electrophoresis of human sera.
    BECH V; BIRCH-ANDERSEN A
    Acta Pathol Microbiol Scand; 1960; 49():98-106. PubMed ID: 13797999
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the development of complement fixing antibodies in measles patients. Observations during a measles epidemic in Greenland.
    BECH V
    J Immunol; 1959 Sep; 83():267-75. PubMed ID: 13798001
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between complement fixing antibodies against measles virus and canine distemper virus.
    BECH V
    Acta Pathol Microbiol Scand; 1960; 50():331-4. PubMed ID: 13688353
    [No Abstract]   [Full Text] [Related]  

  • 6. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.
    Polack FP; Hoffman SJ; Crujeiras G; Griffin DE
    Nat Med; 2003 Sep; 9(9):1209-13. PubMed ID: 12925847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the content of complement fixing measles antibodies in Cohn fractionated gamma globulin. Attempts to reduce anticomplementary activity.
    BECH V
    Acta Pathol Microbiol Scand; 1960; 49():107-13. PubMed ID: 13798000
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between canine distemper and measles virus neutralizing capacities in human sera.
    CARLSTROM G
    Arch Gesamte Virusforsch; 1959; 8(5):539-48. PubMed ID: 13650526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on immunity to measles. I. Studies on measles antibodies in human sera].
    Egami T
    Kumamoto Igakkai Zasshi; 1966 May; 40(5):525-38. PubMed ID: 6012913
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles.
    CUTCHINS EC
    J Immunol; 1962 Jun; 88():788-95. PubMed ID: 13882798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of hemagglutination-inhibiting antibodies against measles virus and mumps virus and complement-fixing antibodies against the respiratory syncytial virus in subjects of Swat (northwestern Pakistan)].
    Servino V; De Dominicis A; Assumma M
    Arch Ital Sci Med Trop Parassitol; 1968; 49(9):261-6. PubMed ID: 4305033
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles antibodies as related to HL-A types in multiple sclerosis.
    Paty DW; Furesz J; Boucher DW; Rand CG; Stiller CR
    Neurology; 1976 Jul; 26(7):651-5. PubMed ID: 945513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of positivity rates for antibodies against measles, rubella, chickenpox and mumps by assays].
    Terada K; Niizuma T; Daimon Y; Kataoka N; Niki Y
    Kansenshogaku Zasshi; 2000 Aug; 74(8):670-4. PubMed ID: 11019516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The distribution of complement fixing antibodies against measles virus in a sample of population in Emilia-Romagna (author's transl)].
    Re MC; Mazzaracchio R; Nanetti A
    Ann Sclavo; 1980; 22(2):141-6. PubMed ID: 7469536
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.
    Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F
    Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibodies in nasal secretions and sera of children with measles.
    Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
    Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.